Ekso Bionics Holdings designs, develops, and markets exoskeleton products. Co.'s products for rehabilitation applications include: EksoNR, which is a wearable bionic exoskeleton that allows hospitals and other rehabilitation providers to deliver over ground gait therapy and ambulation assistance; Ekso Indego Therapy, which can be custom-sized and provided to patients allowing for swift donning; and Ekso Indego Personal, which enables people with mobility impairments the opportunity to walk independently. Co.'s primary product for able-bodied industrial applications is EVO, which elevates and supports a worker's arms to assist them with tasks ranging from chest height to overhead. The EKSO YTD return is shown above.
The YTD Return on the EKSO YTD return page and across the coverage universe of our site,
is a measure of the total return for a given investment year-to-date for the current calendar year
(up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement
period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely
useful in the context of our country's tax system which taxes gains and income on a calendar year basis.
Thus, researching Year-To-Date Returns is good practice for investors — whether EKSO YTD return or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the EKSO YTD return calculation (with any dividends reinvested as applicable), and to provide a
coverage universe of many stocks and ETFs to be able to compare YTD returns.
|